Navigation Links
Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey
Date:12/3/2008

peutic as a single agent for patients with Stage III or IV metastatic melanoma. Based on advice from clinical experts and detailed guidance received from the U.S. Food and Drug Administration (FDA) in an End-of-Phase 2 meeting, Vical successfully completed a Special Protocol Assessment (SPA) with the FDA for a Phase 3 trial (the Allovectin-7(R) Immunotherapeutic for Metastatic Melanoma, or AIMM trial) for certain patients with Stage III or Stage IV metastatic melanoma. The SPA agreement specifies that the trial design and planned analyses address the study's objectives and the resulting study data could provide the primary basis to support a product license application.

Allovectin-7(R) has been granted orphan drug designation for the treatment of invasive and metastatic melanoma by the FDA's Office of Orphan Products Development. Orphan drug designation provides U.S. marketing exclusivity for seven years if marketing approval is received from the FDA, in addition to certain tax benefits for qualifying expenses.

About the AIMM Trial

Vical is conducting a Phase 3 pivotal trial of the company's Allovectin-7(R) cancer immunotherapeutic as first-line therapy in chemotherapy-naive patients with Stage III or IV metastatic melanoma. The AIMM trial is being conducted in accordance with the SPA agreement at more than 60 clinical sites, and is currently enrolling patients in the United States, Canada and Europe. AnGes MG, Inc., is funding the clinical trial under a collaborative agreement with Vical.

The AIMM trial calls for enrollment of approximately 375 patients with Stage III or IV metastatic melanoma. Patients may have been previously treated with surgery, adjuvant therapy, and/or biotherapy, but cannot have been previously treated with cytotoxic chemotherapy. The patients will be randomized on a 2:1 basis: approximately 250 patients will be treated with Allovectin-7(R) and approximately 125
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
2. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
3. U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vicals Vaxfectin(R) Adjuvant
4. Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months
5. First Published Study of New HPV Test for Developing Countries Shows High Accuracy in Predicting Cervical Disease
6. Karolinska Institutet to Test Vicals Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
7. Karolinska Institute to Test Vicals Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
8. Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data
9. Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH
10. Vical Receives $6.3 Million Payment for Continued Funding of Allovectin-7(R) Phase 3 Trial
11. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will present a ... and New Zealand Forensic Science Society,s 22 nd ... Adelaide, Australia .  Forensic Scientists ... advancements that hyperspectral imaging can bring to examination ... , Director of Product Development at ChemImage, will ...
(Date:8/29/2014)...  In part four of a blog ... as a strategic asset, Mary Baxter, MBA, RPh ... Health,s Innovation Delivery Solutions business, discusses how expanding patient ... and patients. "Every hospital pharmacist knows that ... job in a value-based healthcare world," Baxter says. "For ...
(Date:8/29/2014)... , Aug. 29, 2014  Pacific Medical Data ... new website design . The main website, along ... showcases the company,s new services and content relevant to ... a new streamlined design, viewers can now better understand ... health care practices and create a more visible platform ...
Breaking Medicine Technology:ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4PMDS Announces New Website 2
(Date:8/30/2014)... According to Bloomberg , U.S. ... Takeda Pharmaceutical Co. and Eli Lilly & Co. to ... the drugmakers concealed information about a risk of bladder ... Allen v. Takeda Pharmaceuticals North America Inc. (12-cv-00064), was ... Louisiana (Lafayette).* , According to Bloomberg, Takeda and Lilly ...
(Date:8/30/2014)... CA (PRWEB) August 30, 2014 Ticket Down ... vs. Chile exhibition match next Saturday at Levi's Stadium. ... for diehard soccer fans in the United States due to the ... in just about every major city. Many of these games ... in Brazil this past summer. , Levi’s Stadium is a brand ...
(Date:8/30/2014)... OH (PRWEB) August 30, 2014 United Theological ... first fully online degree, the Master of Theological Studies (MTS). ... in 2-3 years, is designed for students who wish to ... their understanding and capacity to serve the Church and community. ... degree, but now they can attend classes from any location ...
(Date:8/30/2014)... Patients suffering from vitiligo can now discover ... review published by Daily Gossip. , Vitiligo is ... is no wonder that numerous sufferers search for an ... is one of the most appreciated such methods at ... stop the spread of this disorder immediately, while completely ...
(Date:8/30/2014)... 2014 Daily Gossip magazine reveals in ... and panic attacks under control with a simple and ... describes this new method as an anxiety recovery ... and overcome general anxiety related disorders. , What ... fact that it can be accessed by users from ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock A.P.C. Comments on Decision to Uphold $9 Billion Actos Award 2Health News:Mexico vs. Chile Tickets at Levi's Stadium in Santa Clara, CA: TicketDown.com Offers Promo Code for Mexico vs. Chile Exhibition Game on September 6th 2Health News:United Theological Seminary Announces First Fully Online Degree 2Health News:Natural Vitiligo Treatment Review Exposes Fast Method for Skin Repigmentation 2Health News:Panic Away Review Reveals New Natural Remedy for Anxiety Patients 2
... follicular lymphoma who continue on maintenance rituximab therapy ... who do not receive this treatment, according to ... 10 online issue of the Journal of ... with follicular lymphoma respond to initial therapy but ...
... PAUL, Minn., Feb. 10 The Minnesota Nurses Association ... agreement which addresses working conditions during emergency response situations. ... ensure adequate Registered Nurse staffing, the health and safety ... of a natural disaster, catastrophic event, pandemic illness or ...
... Researchers from Penn Medicine announced today the results ... of VRX496 at the 16th Conference on Retroviruses and ... gene therapy product being investigated for the treatment of ... to twelve subjects prior to a controlled scheduled treatment ...
... ASPS, Nearly 15-Million U.S. Working Women Considering Cosmetic ProceduresARLINGTON HEIGHTS, ... news of increasing layoffs, straining economic times, and a belief ... are looking at cosmetic medical procedures to give them a ... compiled by the American Society of Plastic Surgeons (ASPS) of ...
... rate in North Carolina may mimic rest of nation, , , TUESDAY, ... the rate of chronic low back pain has more than doubled ... authors say might reflect what,s happening in the country as a ... said Dr. Timothy S. Carey, a professor of medicine at the ...
... Feb. 10 A news conference to announce the ... to be conducted at UofL and Jewish Hospital will ... The location will be the Abell Administration Center second ... Health Sciences Campus.Speakers will include UofL President James Ramsey; ...
Cached Medicine News:Health News:Rituximab maintenance therapy improves survival in patients with relapsed follicular lymphoma 2Health News:Minnesota Nurses Association and Allina Hospitals and Clinics Forge Emergency Preparedness Agreement 2Health News:Penn Medicine presents HIV gene therapy trial data at CROI 2009 2Health News:Video: Women in the Workforce Link Cosmetic Surgery to Success 2Health News:Chronic Low Back Pain Is on the Rise 2Health News:Chronic Low Back Pain Is on the Rise 3
Use the Oculus Mesotest II before and after IOL or refractive surgery. Selectable Landolt ring positions. Accurate measurements in four contrast levels, with and without glare, independent of the pup...
... state-of-the-art electronic medical record the development of ... a proven, comprehensive electronic medical record designed ... at the point of care and to ... through the Internet. AmkaiCharts chronicles patient history, ...
... Systems Information Technologies invites ... yourself how it's award-winning ... - Practice Management (formerly ... simplify your office processes ...
... lamp is designed to for use with ... lamp offers the popular horizontal style light ... ReSeeVit family of slit lamps that offers ... capture clear, crisp digital images in the ...
Medicine Products: